Clinical Trials Browser

Completed × INDUSTRY × domatinostat × Clear all

Carcinoma, Merkel Cell

NCT03278665 2022-02-04

SENSITIZE

Phase 1/2 Completed

40 enrolled

Dermatologic

Melanoma

NCT01344707 2015-04-01

Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)

Phase 1 Completed

36 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

MERKLIN2

SENSITIZE

Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)